Form 4: Lemaitre Vascular Director Jasinski Acquires Dividend Equivalent Rights
SEC Form 4 Filing
Director Lawrence J. Jasinski acquired dividend equivalent rights related to restricted stock units and performance stock units of Lemaitre Vascular, Inc.
Summary
- On March 28, 2024, Lawrence J. Jasinski, a director of Lemaitre Vascular, Inc., acquired dividend equivalent rights.
- These rights are associated with previously granted restricted stock unit (RSU) and performance stock unit (PSU) awards.
- The dividend equivalent rights vest proportionately with the underlying RSU and PSU awards.
- The acquisitions include 0.476 rights related to a 2021 RSU award, 0.9644 rights related to a 2022 RSU award, 0.9644 rights related to a 2022 PSU award, and 1.2345 rights related to a 2023 RSU award.
- Each dividend equivalent right represents the economic equivalent of one share of Lemaitre Vascular's common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding the acquisition of dividend equivalent rights, which has a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It reflects the ongoing vesting of previously granted equity awards.
Stakeholder Impact
- The acquisition of dividend equivalent rights has a minimal direct impact on stakeholders.
Key Dates
| Date | Description |
|---|---|
| 12/11/2021 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/12/2022 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/12/2022 | Date of performance stock unit award grant related to dividend equivalent rights. |
| 12/08/2023 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 03/28/2024 | Date of transaction: Acquisition of dividend equivalent rights. |
| 04/01/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.